Nigella sativa (Prophetic Medicine): A Review

Pakistan Journal of Pharmaceutical Sciences

Volumn 30, Issue 1, 2017, Pages 229-234

  Ijaz, Hira ^a   Tulain, Ume Ruqia ^a   Qureshi, Junaid ^b   Danish, Zeeshan ^c   Musayab, Samina ^d   Akhtar, Muhammad Furqan ^e   Saleem, Ammara ^d   Khan, Khanzada Atta Ur Rehman ^f   Zaman, Muhammad ^e   Waheed, Imran ^g   Khan, Imran ^h   Abdel Daim, Mohamed ⁱ  

^a UNIVERSITY OF SARGODHA   (Pakistan)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^c UNIVERSITY OF THE PUNJAB   (Pakistan)

^d GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^e UNIVERSITY OF LAHORE   (Pakistan)

^f UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

^g Akhtar Saeed Medical College   (Pakistan)

^h PUNJAB INSTITUTE OF CARDIOLOGY   (Pakistan)

ⁱ Suez Canal University   (Egypt)

Author keywords

Nigella sativa; Prophetic Medicine; Ranunculaceae; Thymoquinone (TQ) and Nigella sativa oil (NSO)

Indexed keywords

CARNITINE; CURCUMIN; HUMAN SERUM ALBUMIN; NIGELLA SATIVA EXTRACT; NIGELLA SATIVA OIL; NIGELLONE; PLANT MEDICINAL PRODUCT; THIOCTIC ACID; THYMOQUINONE; UNCLASSIFIED DRUG; VEGETABLE OIL; BENZOQUINONE DERIVATIVE; CARAWAY OIL; PLANT EXTRACT;

ANALGESIC ACTIVITY; ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFERTILITY ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERLIPIDEMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ANTIOXYTOXIC ACTIVITY; ANTISCHISTOSOMIASIS ACTIVITY; CONTRACEPTIVE ACTIVITY; DRUG ACTIVITY; HUMAN; LIVER PROTECTION; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; PLANT SEED; PULMONARY PROTECTIVE ACTIVITY; RENAL PROTECTION; REVIEW; STOMACH PROTECTION; TESTICULAR PROTECTIVE ACTIVITY; TRADITIONAL MEDICINE; TRANQUILIZING ACTIVITY; ANIMAL; BLACK CUMIN; CHEMISTRY; DOSE RESPONSE; HISTORY; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY;

ANIMALS; BENZOQUINONES; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTORY, ANCIENT; HUMANS; MEDICINE, TRADITIONAL; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT OILS; PLANTS, MEDICINAL; SEEDS;

EID: 85008627359     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Abdel-Daim, MM & Ghazy (2015). Effects of Nigella sativa oil and ascorbic acid against oxytetracycline-induced hepato-renal toxicity in rabbits. : Iran J Basic Med Sci., 18(3): 221-227
2. Abdel-Sater KA (2009). Gastro protective effects of Nigella sativa oil on the formation of stress gastritis in hypothyroidal rats. Int. J. Physio. patho and Pharmacoly., 1(2): 143-147.
3. Aboul-Ela EI (2002). Cytogenetic studies on Nigella sativa seeds extract and thymoquinone on mouse cells infected with schistosomiasis using karyotyping. Mutat. Res. Genet Tox., 516(1): 11-17.
4. Ahmad A, Husain A, Mujeeb, M Khan, Najmi, Siddique and Anwar (2013). A review on therapeutic potential of Nigella sativa: A miracle herb. Asian. Pac. J. Trop. Med., 3(5): 337-352.
5. Al Mofleh IA, Alhaider, Mossa, Al-Sohaibani, Al-Yahya, Rafatullah S and Shaik SA (2008). Gastro protective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi. J. Gastroenterology, 14(3): 147-155.
6. Alenzi FQ, El-Bolkiny YS and Salem ML (2010). Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Brit. J. Biomed. Sci., 67(1): 20-28.
7. Al-Ghamdi MS (2001). The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J. Ethnopharmacol., 76(1): 45-48.
8. Al-Hader A, Aqel M and Hasan Z (1993). Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Pharm. Bio., 31(2): 96-100.
9. Aqel M and Shaheen R (1996). Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharmacol, 52(1): 23-26.
10. Azeiz AZ, Saad AH and Darweesh MF (2013). Efficacy of Thymoquinone against Vaginal Candidiasis in Prednisolone-induced Immunosuppressed Mice. J. Am. Sci., 9(4): 155-159.
11. Benkaci-Ali F, Baaliouamer A, Meklati BY and Chemat F (2007). Chemical composition of seed essential oils from Algerian Nigella sativa extracted by microwave and hydro distillation. Flavour. Frag. J., 22(2): 148-153.
12. Boskabady MH, Mohsenpoor N and Takaloo L (2010). Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine, 17(10): 707-713.
13. Chehl N, Chipitsyna G, Gong Q, Yeo CJ and Arafat HA (2009). Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB, 11(5): 373-381.
14. Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C and Attia H (2008). Sterol composition of black cumin (Nigella sativa L.) and aleppo pine (Pinus halepensis Mill) seed oils. J. Food. Compos. Anal, 21(2): 162-168.
15. Daba MH and Abdel-Rahman MS (1998). Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett, 95(1): 23-29.
16. flW, Clin. Phar., 22(4): 447-452.
17. Demir H, Kanter M, Coskun O, Uz YH, Koc A and Yildiz A (2006). Effect of black cumin (Nigella sativa) on heart rate, some hematological values, and pancreatic P-cell damage in cadmium-treated rats. Biol. Trace. Elem. Res., 110(2): 151-162.
18. El-Dakhakhny M, Mady N, Lembert N and Ammon HP (2002). The hypoglycemic effect of Nigella sativa oil is mediated by extra pancreatic actions. Planta. Med, 68(5): 465-466.
19. Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H and Takewaki T (2004). Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res. Vet. Sci., 77(2): 123-129.
20. Gali-Muhtasib H, El-Najjar N and Schneider-Stock R (2006). The medicinal potential of black seed (Nigella sativa) and its components. Adv. Phytomed, 2(4): 133-153.
21. Gökçe A, Oktar S, Koc A, Gonenci R, Yalcinkaya F, Yonden Z and Duru M (2010). Protective effect of thymoquinone in experimental testicular torsion. Urol. Int., 5(4): 857-866.
22. Hawsawi ZA, Ali BA and Bamosa AO (2001). Effect of Nigella sativa (black seed) and thymoquinone on blood glucose in albino rats. Annal Saudi Med., 21(4): 242-244.
23. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M and Mansouri MT (2005). Intra cerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Int. J. Exp. Clin. Res., 11(4): 102-106.
24. Ilhan A, Gurel A, Armutcu F, Kamisli S and Iraz M (2005). Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacol, 49(4): 456-464.
25. Isik AF, Kati I, Bayram I and Ozbek H (2005). A new agent for treatment of acute respiratory distress syndrome: Thymoquinone. An experimental study in a rat model. Eur. J. Cardio-Thorac., 28(2): 301-305.
26. Ismail MYM (2009). Therapeutic Role of Prophetic Medicine Habbat El Baraka (Nigella sativa L.)-A Review. World Appl. Sci. J., 7(9): 1203-1208.
27. Jabbar A, Raza MA, Iqbal Z and Khan MN (2006). An inventory of the ethnobotanicals used as anthelmintics in the southern Punjab (Pakistan). J. Ethnopharmacol., 108(1): 152-154.
28. Kaleem M, Kirmani D, Asif M, Ahmed Q and Bano B (2006). Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J. Exp. Biol., 44(9): 745.
29. Kanter M (2008). Nigella sativa and derived thymoquinone prevents hippocampal neuro-degeneration after chronic toluene exposure in rats. Neurochem. Res., 33(3): 579-588.
30. Khan MA, Ashfaq MK, Zuberi HS, Mahmood MS and Gilani AH (2003). The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds. Phytother. Res., 17(2): 183-186.
31. Khan A, Chen HC, Tania M and Zhang DZ (2011). Anticancer activities of Nigella sativa (black cumin). Afr. J. Comp. Clin. Exp. Med., 8(5): 143-149.
32. Kumara SS and Huat BT (2001). Extraction, isolation and characterisation of antitumor principle, α-hederin, from the seeds of Nigella sativa. Planta. Med., 67(1): 29-32.
33. Landa P, Kokoska L, Pribylova M, Vanek T and Marsik P (2009). In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E2 biosynthesisb. Arch. Pharmacol. Res., 32(1): 75-78.
34. Meddah B, Ducroc R, El-Abbas, Faouzi M, Eto B, Mahraoui L, Benhaddou-Andaloussi A and Haddad PS (2009). Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J. Ethnopharmacol., 121(3): 419-424.
35. Meral I, Yener Z, Kahraman T and Mert N (2001). Effect of Nigella sativa on glucose concentration, Lipid peroxidation, Anti-Oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J. Vet. Med. Ser. A., 48(10): 593-599.
36. Najmi A, Nasiruddin M, Khan RA and Haque SF (2008). Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int. J. Diabetes Dev. Countries., 28(1): 11-17.
37. Perveen T, Haider S, Kanwal S and Haleem DJ (2009). Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. Pak. J. Pharm Sci., 22(2): 143-149.
38. Rajkapoor B, Anandan R and Jayakar B (2002). Anti-ulcer effect of Nigella sativa Linn against gastric ulcers in rats. Curr. Sci. India, 82(2): 177-178.
39. Randhawa MA and Alghamdi MS (2011). Anticancer activity of Nigella Sativa (Black Seed) A Review. Am. J. Chinese. Med., 39(6): 1075-1091.
40. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM and Randhawa MA (2010). Comparative study of Nigella sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J. Gastroentology, 16(3): 12-18.
41. Shenawy EL, Nahla S, Soliman MF and Reyad SI (2008). The effect of antioxidant properties of aqueous garlic extract and Nigella sativa as anti-schistosomiasis agents in mice. J. Instit. Trop. Med., 50(1): 29-36.
42. Sultan MT, Butt MS, Anjum FM, Jamil A, Akhtar S and Nasir M (2009). Nutritional profile of indigenous cultivar of black cumin seeds and antioxidant potential of its fixed and essential oil. Pak. J. Bot., 41(3): 1321-1330.
43. Tembhurne S, Feroz BH, More DM and Sakarkar (2014). A review on therapeutic potential of Nigella sativa (kalonji) seeds. J. Med. Plants Res., 8(3): 167-177.
44. Terzi A, Coban S, Yildiz F, Ates M, Bitiren M, Taskin A and Aksoy N (2010). Protective effects of Nigella sativa on intestinal ischemia-reperfusion injury in rats. J. Invest. Surg., 23(1): 21-27.
45. Thomas TJ, Panikkar B, Subramoniam A, Nair MK and Panikkar KR (2002). Antitumour property and toxicity of Barringtonia racemosa Roxb seed extract in mice. J. Ethnopharmacol., 82(2): 223-227.
46. Üstun G, Kent L, Cekin N and Civelekoglu H (1990). Investigation of the technological properties of Nigella sativa (black cumin) seed oil. J. Am. Oil Chem. Soc., 67(12): 958-960.
47. Yaman İ and Balikci E (2010). Protective effects of Nigella sativa against gentamicin-induced nephrotoxicity in rats. Exp. Toxicol. Pathol., 62(2): 183-190.
48. Yildiz F, Coban S, Terzi A, Savas M, Bitiren M, Celik H and Aksoy N (2010). Protective effects of Nigella sativa against ischemia-reperfusion injury of kidneys. Renal Failure, 32(1): 126-131.